G E Pakes
Overview
Explore the profile of G E Pakes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
526
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Blick G, Greiger-Zanlungo P, Gretz S, Han J, Dupree D, Garton T, et al.
Int J STD AIDS
. 2012 May;
23(3):e18-22.
PMID: 22581890
In a retrospective database study at two HIV treatment centres, medical records were accessed to evaluate long-term efficacy and safety parameters in all HIV-infected adults who had achieved HIV-1 RNA...
2.
Chen J, Garner R, Lee L, Seymour M, Fuchs E, Hubbard W, et al.
Clin Pharmacol Ther
. 2010 Oct;
88(6):796-800.
PMID: 20981003
Accelerator mass spectrometry (AMS) is an ultrasensitive technique to detect radiolabeled compounds. We administered a microdose (100 µg) of (14)C-labeled zidovudine (ZDV) with or without a standard unlabeled dose (300...
3.
Luber A, Condoluci D, Slowinski P, Andrews M, Olson K, Peloquin C, et al.
HIV Med
. 2009 Oct;
11(3):193-9.
PMID: 19863619
Objective An open-label, three-period pharmacokinetic study was conducted to investigate the drug interaction potential between fosamprenavir (FPV) and tenofovir disoproxil fumarate (TDF). Methods Thirty-six healthy subjects received TDF 300 mg...
4.
Sleasman J, Robbins B, Cross S, Lindsey J, Kraimer J, Heckman B, et al.
Clin Pharmacol Ther
. 2009 Jan;
85(4):394-401.
PMID: 19118380
The pharmacokinetics of abacavir and its metabolites were investigated in 30 human immunodeficiency virus (HIV)-infected adolescents and young adults 13-25 years of age, equally divided into two groups: <18 years...
5.
Kumar P, Rodriguez-French A, Thompson M, Tashima K, Averitt D, Wannamaker P, et al.
HIV Med
. 2006 Jan;
7(2):85-98.
PMID: 16420253
Objectives: To compare the lipid and metabolic effects, efficacy, and safety of twice-daily regimens of Trizivir (abacavir 300 mg/lamivudine 150 mg/zidovudine 300 mg triple nucleoside tablet; TZV), Combivir (lamivudine 150...
6.
DeMasi R, Graham N, Tolson J, Pham S, Capuano G, Fisher R, et al.
Adv Ther
. 2001 Nov;
18(4):163-73.
PMID: 11697019
The Patient Medication Adherence Questionnaire Version 1.0 (PMAQ-V1.0) is a patient-reported adherence instrument to assess medication-taking behaviors and identify barriers to adherence with antiretroviral therapy. To assess the correlation between...
7.
Moodley D, Pillay K, Naidoo K, Moodley J, Johnson M, Moore K, et al.
J Clin Pharmacol
. 2001 Jul;
41(7):732-41.
PMID: 11452705
A phase I, repeat-dose, open-label study was conducted to determine the pharmacokinetics and safety of zidovudine and lamivudine, coadministered orally every 12 hours, in 16 neonates whose mothers were infected...
8.
Pakes G
Ann Pharmacother
. 2001 Jun;
35(6):770-9.
PMID: 11408997
Once researchers have completed a clinical trial and analyzed the data, they have a duty to make the results known to their peers by writing a manuscript suitable for publication...
9.
Moore K, Yuen G, Hussey E, Pakes G, Eron Jr J, Bartlett J
Antimicrob Agents Chemother
. 1999 Dec;
43(12):3025-9.
PMID: 10582904
Lamivudine population pharmacokinetics were investigated by using nonlinear mixed-effect modelling (NONMEM) analysis of data from 394 human immunodeficiency virus (HIV)-infected patients treated with lamivudine (150 to 300 mg every 12...
10.
Moore K, Barrett J, Shaw S, Pakes G, Churchus R, Kapoor A, et al.
AIDS
. 1999 Nov;
13(16):2239-50.
PMID: 10563709
Objective: To assess the pharmacokinetics of lamivudine phosphorylation in peripheral blood mononuclear cells (PBMC) from patients infected with HIV-1. Design: Single-center, open-label, randomized, two-period, cross-over study in 10 asymptomatic, antiretroviral-experienced,...